Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts
Paolo Tarantino is a Breast Medical Oncologist and Researcher. He’s currently pursuing an Advanced Research Fellowship at Dana-Farber Cancer Institute at Harvard Medical School (Boston, MA) and a PhD in clinical research at the University of Milan. His research focuses on the study of the HER2 oncoprotein, the biology of HER2-low breast tumors and the development of novel antibody-drug conjugates.
Session 22: HER2-Low Breast Cancer: Limits of Testing and Where to Go from Here
Friday, May 5, 2023
4:45 PM – 5:20 PM ET
Friday, May 5, 2023
5:20 PM – 5:30 PM ET
Session 13: Debate: Should We Quantify HER-2 Expression for Use of TDXd and Other ADCs? - NO
Thursday, November 2, 2023
3:45 PM – 4:00 PM ET
Thursday, November 2, 2023
4:15 PM – 4:30 PM ET
Session 21: HER2-Low Breast Cancer: Limits of Testing and Where To Go From Here
Friday, November 3, 2023
3:30 PM – 4:05 PM ET
Friday, November 3, 2023
4:05 PM – 4:15 PM ET